Empowered Funds’s Fulgent Genetics FLGT Stock Holding History

Empowered Funds’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$276K	Buy	+13,446	New	+$228K	﹤0.01%	1887
2025 Q2	–	Sell	-22,670	Closed	-$383K	–	1788
2025 Q1	$383K	Sell	22,670 -72,341	-76%	-$1.23M	0.01%	1322
2024 Q4	$1.75M	Buy	95,011 +4,609	+5%	+$90K	0.03%	787
2024 Q3	$1.96M	Buy	90,402 +4,556	+5%	+$102K	0.03%	681
2024 Q2	$1.68M	Sell	85,846 -23,321	-21%	-$487K	0.03%	664
2024 Q1	$2.37M	Buy	109,167 +8,225	+8%	+$204K	0.04%	550
2023 Q4	$2.92M	Buy	100,942 +9,024	+10%	+$241K	0.07%	391
2023 Q3	$2.46M	Buy	91,918 +7,426	+9%	+$254K	0.07%	393
2023 Q2	$3.13M	Buy	+84,492	New	+$2.95M	0.11%	252

Other funds holding FLGT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Empowered Funds's FLGT Position: Q2 2026 in Review

Empowered Funds opened a new position in Fulgent Genetics (FLGT) in Q2 2026: 13,446 shares worth $276K. The stake represents ﹤0.01% of the portfolio and ranks #1887 among its holdings. This is a return to the name: Empowered Funds previously reported a position in FLGT as recently as Q1 2025.

Empowered Funds first reported a position in FLGT in Q2 2023 and has held it in 9 quarters since. The position peaked at $3.13M in Q2 2023. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

Empowered Funds held 13,446 shares of Fulgent Genetics worth $276K as of Q2 2026.
Fulgent Genetics was a new Empowered Funds position in Q2 2026.
Fulgent Genetics made up ﹤0.01% of Empowered Funds's portfolio in Q2 2026, its #1887 holding.
Empowered Funds first reported a position in Fulgent Genetics in Q2 2023 and has held it in 9 quarters since.
Empowered Funds's Fulgent Genetics position peaked at $3.13M in Q2 2023.
141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.